seed
Stage
2020
Founded
1
Investors
About
Kano Therapeutics is developing a novel DNA-based modality to enable safe, effective and flexible in vivo correction of genetic diseases, advancing gene therapy approaches for therapeutic use.
Explore Kano Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.